Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

365
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
365
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K
Anatomy of the Intestines01:23

Anatomy of the Intestines

72.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Oriented Pt Deposition via Micro-Nano Crisscross Scaffolds: A Paradigm for High-Efficiency HER Catalyst.

ChemSusChem·2026
Same author

Linagliptin loaded chitosan nanoparticles for the efficient therapy of renal fibrosis.

Frontiers in pharmacology·2026
Same author

NEK2 amplification as a biomarker of poor prognosis across multiple cancers.

Chinese medical journal·2026
Same author

DOF gene family in P. sativum (L.): comprehensive genomic identification, phylogenetic examination, evolutionary growth, and expression analysis.

BMC genomics·2025
Same author

Screen use in pediatric cancer patients: A hospital-based study.

Journal of pediatric nursing·2025
Same author

Letter to the Editor-"Artificial sweetener and respiratory system cancer: A Mendelian randomization analysis".

Clinical nutrition ESPEN·2025

Related Experiment Video

Updated: Jul 30, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K

Intestinal Microbes and Hematological Malignancies.

Yinghong Zhu1,2, Qiaohui Yang3, Qin Yang4

  • 1Haihe Laboratory of Cell Ecosystem, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Geriatric Disorders, Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.

Cancers
|May 16, 2023
PubMed
Summary

The gut microbiome influences hematological malignancies like leukemia and lymphoma. Understanding this connection may reveal new therapeutic targets to improve patient survival.

Keywords:
clinical featureshematological malignanciesinitiationintestinal microbesprogression

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

12.3K

Related Experiment Videos

Last Updated: Jul 30, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

12.3K

Area of Science:

  • Oncology
  • Microbiology
  • Hematology

Background:

  • Hematological malignancies exhibit high mortality and complex risk factors beyond genetics and microenvironment.
  • The gut microbiome's role in cancer development is increasingly recognized.
  • Existing models struggle to fully predict hematological malignancy risk.

Purpose of the Study:

  • To explore the intricate relationship between intestinal microbes and hematological malignancies.
  • To elucidate the mechanisms by which gut microbes influence cancer initiation and progression.
  • To identify potential therapeutic strategies targeting the gut microbiome for improved patient outcomes.

Main Methods:

  • Literature review and synthesis of recent research findings.
  • Analysis of studies investigating the gut microbiome's impact on hematological tumors.
  • Focus on specific malignancies: leukemia, lymphoma, and multiple myeloma.

Main Results:

  • Gut microbes are significantly correlated with the onset and progression of hematological malignancies.
  • Both direct and indirect mechanisms mediate the influence of gut microbiota.
  • The gut microbiome affects therapeutic efficacy in these cancers.

Conclusions:

  • The intestinal microbiome is a critical factor in hematological malignancy development and progression.
  • Targeting the gut microbiome presents a promising avenue for novel therapeutic interventions.
  • Further research into gut microbial therapies could enhance survival rates for patients with leukemia, lymphoma, and multiple myeloma.